NYSE: BMEZ

BlackRock Health Sciences Term Trust (BMEZ)

BlackRock Health Sciences Term Trust is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker BMEZ. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
BMEZ
Exchange
NYSE
SEC CIK
1785971
Official filings
SEC EDGAR

Research BMEZ

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is BlackRock Health Sciences Term Trust's stock ticker?

BlackRock Health Sciences Term Trust trades under the ticker symbol BMEZ on NYSE. Its SEC Central Index Key (CIK) is 1785971.

Where can I read BlackRock Health Sciences Term Trust's SEC filings?

The BMEZ SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports BlackRock Health Sciences Term Trust has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze BMEZ's financial statements?

The BMEZ Financials page shows BlackRock Health Sciences Term Trust's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does BMEZ compare with its peers and the market?

The BMEZ Peer Comparison page lines BlackRock Health Sciences Term Trust up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.